Role of B-cells in Mycosis Fungoides

被引:15
作者
Nielsen, Pia Rude [1 ,2 ]
Eriksen, Jens Ole [1 ]
Sorensen, Mia Dahl [3 ]
Wehkamp, Ulrike [4 ]
Lindahl, Lise M. [5 ]
Bzorek, Michael [1 ]
Iversen, Lars [5 ]
Woetman, Anders [2 ]
Odum, Niels [2 ]
Litman, Thomas [2 ]
Gjerdrum, Lise Mette Rahbek [1 ,6 ]
机构
[1] Zealand Univ Hosp, Dept Pathol, DK-4000 Roskilde, Denmark
[2] Univ Copenhagen, Leo Fdn Skin Immunol Res Ctr, Dept Immunol & Microbiol, Copenhagen, Denmark
[3] Odense Univ Hosp, Dept Pathol, Odense, Denmark
[4] Univ Hosp, Dept Dermatol, Kiel, Germany
[5] Aarhus Univ Hosp, Dept Dermatol, Aarhus, Denmark
[6] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark
关键词
B-cells; cutaneous T-cell lymphoma; mycosis fungoides; tumour microenvironment; SEZARY-SYNDROME; LYMPHOMA; EXPRESSION; CLASSIFICATION; MICRORNA; DISEASE; LANDSCAPE; RITUXIMAB; FEATURES;
D O I
10.2340/00015555-3775
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Mycosis fungoides is the most common type of cutaneous T-cell lymphoma. The inflammatory microenvironment in mycosis fungoides is complex. There is accumulating evidence that the neoplastic T-cells take control of the microenvironment and thereby promote their own expansion by suppressing cellular immunity. B-cells have proved to be upregulated in large-cell transformed mycosis fungoides, and could potentially play a role in disease progression. To investigate the presence of B-cells in mycosis fungoides compared with controls, this study analysed 85 formalin-fixed and paraffin-embedded mycosis fungoides biopsies. MS4A1 gene expression was significantly upregulated in mycosis fungoides compared with controls (p < 0.0001) and further upregulated in disease progression, (p = 0.001). Digital quantification of PAX5+/ CD20+ cells confirmed the increased presence of Bcells in mycosis fungoides compared with controls. No co-labelling of CD3/CD20 was observed in the neoplastic T-cells. This study found a significantly increased presence of B-cells in the tumour-associated microenviron ment in mycosis fungoides. These findings could potentially lead to new treatment strategies for mycosis fungoides.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Homeopathy as Therapy for Mycosis Fungoides: Case Reports of Three Patients
    Nwabudike, Lawrence Chukwudi
    HOMEOPATHY, 2019, 108 (04) : 277 - 284
  • [22] Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sezary Syndrome
    Virmani, Pooja
    Zain, Jasmine
    Rosen, Steven T.
    Myskowski, Patricia L.
    Querfeld, Christiane
    DERMATOLOGIC CLINICS, 2015, 33 (04) : 807 - +
  • [23] Phototherapy of mycosis fungoides
    Trautinger, Franz
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2017, 152 (06): : 597 - 606
  • [24] Hyperpigmented mycosis fungoides: a retrospective and comparative analysis with other subtypes of mycosis fungoides
    Jung, Joon Min
    Lee, Mi Young
    Won, Chong Hyun
    Chang, Sung Eun
    Lee, Mi Woo
    Lee, Woo Jin
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1598 - 1606
  • [25] Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways
    Perez, C.
    Mondejar, R.
    Garcia-Diaz, N.
    Cereceda, L.
    Leon, A.
    Montes, S.
    Duran Vian, C.
    Perez Paredes, M. G.
    Gonzalez-Moran, A.
    Alegre de Miguel, V.
    Sanz Anquela, J. M.
    Frias, J.
    Limeres, M. A.
    Gonzalez, L. M.
    Martin Davila, F.
    Beltran, M.
    Mollejo, M.
    Mendez, J. R.
    Gonzalez, M. A.
    Gonzalez Garcia, J.
    Lopez, R.
    Gomez, A.
    Izquierdo, F.
    Ramos, R.
    Camacho, C.
    Rodriguez-Pinilla, S. M.
    Martinez, N.
    Vaque, J. P.
    Ortiz-Romero, P. L.
    Piris, M. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (01) : 147 - 155
  • [26] Mogamulizumab in the treatment of advanced mycosis fungoides and Sezary syndrome: safety and efficacy
    Lewis, Daniel J.
    Rook, Alain H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (06) : 447 - 452
  • [27] Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors
    Pulitzer, Melissa
    Myskowski, Patricia L.
    Horwitz, Steven M.
    Querfeld, Christiane
    Connolly, Brian
    Li, Janet
    Murali, Rajmohan
    PATHOLOGY, 2014, 46 (07) : 610 - 616
  • [28] Clinicopathologic characteristics and outcomes of patients with mycosis fungoides
    Alghubaywi, Faisal A.
    Alharthi, Sawsan A.
    Aldharman, Sarah S.
    Najjar, Raneem H.
    Aleissa, Majed Y.
    Aljarbou, Ohoud Z.
    AlJasser, Mohammed I.
    Almohideb, Mohammad A.
    SAUDI MEDICAL JOURNAL, 2023, 44 (04) : 394 - 400
  • [29] Mycosis fungoides with spongiosis: A potential diagnostic pitfall
    Shamim, Huma
    Johnson, Emma F.
    Gibson, Lawrence E.
    Connferet, Nneka
    JOURNAL OF CUTANEOUS PATHOLOGY, 2019, 46 (09) : 645 - 652
  • [30] CD30 Expression and Proliferative Fraction in Nontransformed Mycosis Fungoides
    Edinger, James T.
    Clark, Beth Z.
    Pucevich, Brian E.
    Geskin, Larisa J.
    Swerdlow, Steven H.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (12) : 1860 - 1868